An Exploratory Study of Nesiritide in Participants With Acute Heart Failure
NCT00490724
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure, Congestive
Interventions
DRUG:
Nesiritide (1+0.01)
DRUG:
Nesiritide (2+0.005)
DRUG:
Nesritide (2+0.01)
Sponsor
Janssen Pharmaceutical K.K.